Open Mdispenza Dissertation.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Open Mdispenza Dissertation.Pdf The Pennsylvania State University The Graduate School Physiology Graduate Program IMMUNOMODULATORY EFFECTS OF ISOTRETINOIN IN VIVO A Dissertation in Physiology by Melanie Claire Dispenza 2011 Melanie Claire Dispenza Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy December 2011 The dissertation of Melanie Claire Dispenza was reviewed and approved* by the following: Diane M. Thiboutot Professor of Dermatology Dissertation Advisor Chair of Committee Robert H. Bonneau Professor of Microbiology and Immunology and Pediatrics Charles H. Lang Distinguished Professor of Cellular and Molecular Physiology Program Director for Physiology Gary A. Clawson Professor of Pathology Stephen R. Rannels Associate Professor of Cellular and Molecular Physiology *Signatures are on file in the Graduate School ii ABSTRACT Acne is a common human ailment that can cause significant physical and psychological morbidity. Though it is thought to be partially caused by Propionibacterium acnes colonization, studies suggest that patients‟ specific immune responses to P.acnes may play a larger role in acne than the pathogenicity of P.acnes itself. Isotretinoin, a pro-drug for retinoic acid, is the only agent that induces a permanent remission of acne, but the mechanism underlying its long-term efficacy is unknown. We hypothesized that modulation of the immune response to P.acnes is key to isotretinoin‟s ability to induce long-term or permanent remissions of acne. In this Thesis, we show that acne patients‟ monocytes express higher levels of TLR-2 and secrete more IL-1β, IL-6, IL-8, IL-10, and IL-12 in response to P. acnes than monocytes from normal volunteers. Isotretinoin therapy significantly decreases TLR-2 expression and inflammatory cytokine secretion by acne patients‟ monocytes compared to baseline. These changes continue through 20 weeks of isotretinoin therapy and persist for at least six months after the cessation of therapy, indicating that modification of patients‟ immune responses to P. acnes may represent a long-term mechanism by which isotretinoin can cure acne. Because the exogenous administration of retinoids causes severe side-effects including birth defects, studies characterizing the action of isotretinoin in humans in vivo are lacking. This is the first study to show that isotretinoin has immunomodulatory effects in acne patients in vivo. Findings from this study extend to other diseases for which isotretinoin is used as a therapy as well as inflammatory disorders characterized by TLR-2 over-expression. iii TABLE OF CONTENTS List of Figures .................................................................................................................................... vii List of Tables ...................................................................................................................................... xiv List of Abbreviations .......................................................................................................................... xv Acknowledgements ............................................................................................................................ xvii Chapter 1: Literature Review ........................................................................................................ 1 1.1 Introduction ......................................................................................................................... 1 1.2 Skin ...................................................................................................................................... 2 1.2.1 Structure of the skin .................................................................................................. 2 1.2.1.1 Epidermis ....................................................................................................... 2 1.2.1.2 Dermis and hypodermis ................................................................................. 3 1.2.1.3 Sebaceous glands ........................................................................................... 4 1.2.2 Immune function of the skin ..................................................................................... 5 1.2.2.1 Innate immunity in the skin ........................................................................... 6 1.2.2.2 Antigen presenting and phagocytic cells........................................................ 10 1.2.2.3 T cells ............................................................................................................. 12 1.2.2.4 Regulatory T cells .......................................................................................... 14 1.3 Acne ..................................................................................................................................... 16 1.3.1 Epidemiology ............................................................................................................ 16 1.3.2 Pathophysiology........................................................................................................ 17 1.3.2.1 Follicular hyperkeratinization ........................................................................ 17 1.3.2.2 Excess sebum production ............................................................................... 18 1.3.2.3 P.acnes and inflammation .............................................................................. 19 1.3.3 Current treatments for acne ....................................................................................... 22 1.3.3.1 Topical treatments .......................................................................................... 22 1.3.3.2 Systemic treatments ....................................................................................... 23 1.3.3.3 Isotretinoin ..................................................................................................... 24 1.3.4 Model systems for acne research .............................................................................. 25 1.3.4.1 Cell lines ........................................................................................................ 25 1.3.4.2 Animal models ............................................................................................... 26 1.3.4.3 Human subjects .............................................................................................. 27 1.4 Retinoids .............................................................................................................................. 27 1.4.1 Retinoid biology, function, and metabolism ............................................................. 27 1.4.2 Retinoid effects on the immune system .................................................................... 33 1.4.2 Mechansims of retinoids in acne therapy.................................................................. 37 1.5 Significance of research project ........................................................................................... 40 Chapter 2: Systemic Isotretinoin Treatment Modulates Acne Patients’ Immune Response to P. acnes .................................................................................................................................. 42 2.1 Chapter abstract ................................................................................................................... 42 2.2 Introduction ......................................................................................................................... 42 2.3 Results ................................................................................................................................. 43 2.3.1 Subject demographics ............................................................................................... 43 iv 2.3.2 All enrolled patients responded clinically to isotretinoin therapy ............................ 45 2.3.3 Serum concentrations of retinoids do not differ between acne patients and normal volunteers .................................................................................................................... 46 2.3.4 Acne patients have higher serum concentrations of IL-10, but not inflammatory cytokines, compared to healthy volunteers ................................................................. 46 2.3.5 Isotretinoin therapy down-regulates surface expression of TLR-2 on acne patients‟ monocytes in vivo ....................................................................................................... 49 2.3.6 TLR-2 expression on peripheral blood monocytes does not correlate with age ....... 51 2.3.7 Acne patients‟ monocytes express lower levels of TLR-4 than normal volunteers‟................................................................................................................... 53 2.3.8 Isotretinoin therapy decreases inflammatory cytokine production by acne patients‟ monocytes in response to P. acnes.............................................................................. 54 2.3.9 Isotretinoin therapy does not affect TLR-2 expression in the epidermis of acne patients as determined by immunohistochemistry ...................................................... 56 2.3.10 Isotretinoin therapy does not affect proportions of Treg in peripheral blood ........... 59 2.3.11 Lymphocyte proliferation in response to P. acnes is blunted in acne patients compared to normal volunteers ................................................................................... 61 2.3.12 Isotretinoin therapy does not affect
Recommended publications
  • Downloaded and Searched Against the Dbest Database to Identify Ests
    BMC Genomics BioMed Central Research article Open Access A transcription map of the 6p22.3 reading disability locus identifying candidate genes Eric R Londin1, Haiying Meng2 and Jeffrey R Gruen*2 Address: 1Graduate Program in Genetics, State University of New York at Stony Brook, NY, USA and 2Yale Child Health Research Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA Email: Eric R Londin - [email protected]; Haiying Meng - [email protected]; Jeffrey R Gruen* - [email protected] * Corresponding author Published: 30 June 2003 Received: 22 April 2003 Accepted: 30 June 2003 BMC Genomics 2003, 4:25 This article is available from: http://www.biomedcentral.com/1471-2164/4/25 © 2003 Londin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. reading disabilitydyslexia6p22.3In silicoESTs Abstract Background: Reading disability (RD) is a common syndrome with a large genetic component. Chromosome 6 has been identified in several linkage studies as playing a significant role. A more recent study identified a peak of transmission disequilibrium to marker JA04 (G72384) on chromosome 6p22.3, suggesting that a gene is located near this marker. Results: In silico cloning was used to identify possible candidate genes located near the JA04 marker. The 2 million base pairs of sequence surrounding JA04 was downloaded and searched against the dbEST database to identify ESTs. In total, 623 ESTs from 80 different tissues were identified and assembled into 153 putative coding regions from 19 genes and 2 pseudogenes encoded near JA04.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020)
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School March 2020 Mass Spectrometry Discovery-Based Proteomics to Examine Anti- Aging Effects of the Nutraceutical NT-020 in Rat Serum Samantha M. Portis University of South Florida Follow this and additional works at: https://scholarcommons.usf.edu/etd Part of the Bioinformatics Commons, and the Neurosciences Commons Scholar Commons Citation Portis, Samantha M., "Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020). Graduate Theses and Dissertations. https://scholarcommons.usf.edu/etd/8279 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum by Samantha M. Portis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Medical Sciences with a concentration in Neuroscience Department of Molecular Pharmacology and Physiology College of Medicine University of South Florida Major Professor: Paul R. Sanberg, Ph.D., D.Sc Co-Major Professor: Paula C. Bickford, Ph.D. Kevin Nash, Ph.D. Dominic D’Agostino, Ph.D. Brent Small, Ph.D. Date of Approval: March 28, 2020 Keywords: aging, proteome, serum, inflammation, bioinformatics Copyright © 2020, Samantha M. Portis Dedication I dedicate this work to my family, Alan, Candace, Carolyn, and Jimmy, my brother, Patrick, and my partner, Will.
    [Show full text]
  • SNV Discovery and Functional Candidate Gene Identification For
    RESEARCH ARTICLE SNV discovery and functional candidate gene identification for milk composition based on whole genome resequencing of Holstein bulls with extremely high and low breeding values Shan Lin1, Hongyan Zhang1, Yali Hou2, Lin Liu3, Wenhui Li1, Jianping Jiang1, Bo Han1, 1 1 Shengli Zhang , Dongxiao SunID * a1111111111 1 Department of Animal Genetics and Breeding, College of Animal Science and Technology, Key Laboratory of Animal Genetics and Breeding of the Ministry of Agriculture, National Engineering Laboratory for Animal a1111111111 Breeding, China Agricultural University, Beijing, China, 2 Laboratory of Disease Genomics and Individualized a1111111111 Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China, 3 Beijing Dairy Cattle a1111111111 Center, Beijing, China a1111111111 * [email protected] Abstract OPEN ACCESS Citation: Lin S, Zhang H, Hou Y, Liu L, Li W, Jiang We have sequenced the whole genomes of eight proven Holstein bulls from the four half-sib J, et al. (2019) SNV discovery and functional or full-sib families with extremely high and low estimated breeding values (EBV) for milk pro- candidate gene identification for milk composition tein percentage (PP) and fat percentage (FP) using Illumina re-sequencing technology. based on whole genome resequencing of Holstein Consequently, 2.3 billion raw reads were obtained with an average effective depth of 8.1 . bulls with extremely high and low breeding values. × PLoS ONE 14(8): e0220629. https://doi.org/ After single nucleotide variant (SNV) calling, total 10,961,243 SNVs were identified, and 10.1371/journal.pone.0220629 57,451 of them showed opposite fixed sites between the bulls with high and low EBVs within Editor: Sujan Mamidi, HudsonAlpha Institute for each family (called as common differential SNVs).
    [Show full text]
  • Frequent Loss-Of-Heterozygosity in CRISPR-Cas9–Edited Early Human Embryos
    Frequent loss-of-heterozygosity in CRISPR-Cas9–edited COLLOQUIUM PAPER early human embryos Gregorio Alanis-Lobatoa, Jasmin Zohrenb, Afshan McCarthya, Norah M. E. Fogartya,c, Nada Kubikovad,e, Emily Hardmana, Maria Grecof, Dagan Wellsd,g, James M. A. Turnerb, and Kathy K. Niakana,h,1 aHuman Embryo and Stem Cell Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; bSex Chromosome Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; cCentre for Stem Cells and Regenerative Medicine, Guy’s Campus, King’s College London, SE1 9RT London, United Kingdom; dNuffield Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, OX3 9DU Oxford, United Kingdom; eJesus College, University of Oxford, OX1 3DW Oxford, United Kingdom; fAncient Genomics Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; gJuno Genetics, OX4 4GE Oxford, United Kingdom; and hThe Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EG Cambridge, United Kingdom Edited by Barbara J. Meyer, University of California, Berkeley, CA, and approved October 31, 2020 (received for review June 5, 2020) CRISPR-Cas9 genome editing is a promising technique for clinical homozygous WT embryos in both cases was not associated with applications, such as the correction of disease-associated alleles in use of the provided repair template for gene correction. Instead, somatic cells. The use of this approach has also been discussed in the authors suggest that in edited embryos the WT maternal the context of heritable editing of the human germ line. However, allele served as a template for the high-fidelity homology di- studies assessing gene correction in early human embryos report rected repair (HDR) pathway to repair the double-strand lesion low efficiency of mutation repair, high rates of mosaicism, and the caused by the Cas9 protein in the paternal allele (8).
    [Show full text]
  • Stem-Like Cells and Glial Progenitors in the Adult Mouse Suprachiasmatic Nucleus
    STEM-LIKE CELLS AND GLIAL PROGENITORS IN THE ADULT MOUSE SUPRACHIASMATIC NUCLEUS Dilshan H. Beligala A Dissertation Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY December 2019 Committee: Michael E. Geusz, Advisor Pascal Bizarro Graduate Faculty Representative George S. Bullerjahn HowarD C. Cromwell Paul F. Morris © 2019 Dilshan H. Beligala All Rights Reserved iii ABSTRACT Michael E. Geusz, Advisor Reports have described cells with stem-like protein expression in the hypothalamic suprachiasmatic nucleus (SCN), which contains the principal circadian pacemaker of the body. Additionally, there are oligodendrocyte progenitor cells (OPCs) scattered throughout the SCN and other brain areas with reported abilities to differentiate into neurons and glia. The SCN is a particularly good structure for studying adult neurogenesis because its cellular manipulation has known quantifiable effects on specific parameters of circadian rhythms. The objectives of this study were to characterize stem and progenitor cells in the SCN and to study neurogenesis from SCN OPCs in vitro. We first performed a meta-analysis to identify the expression of stem cell- related genes in the SCN and then used defined serum-free media for inducing stem and progenitor cell proliferation in SCN explant cultures, identified by immunocytochemistry and confocal microscopy. In the meta-analysis, we analyzed 25 genes associated with stem cell maintenance and increased motility, out of which over 90% were expressed at higher levels in the SCN than in other brain areas. In explant cultures maintained in stem and progenitor cell medium (SPM), cells expressed stem cell proteins: SOX2, nestin, MSI2 and OCT4.
    [Show full text]
  • HDL Subclass Proteomic Analysis and Functional Implication of Protein Dynamic Change During HDL Maturation Yuling Zhang Sun Yat-Sen University, China
    University of Kentucky UKnowledge Saha Cardiovascular Research Center Faculty Cardiovascular Research Publications 6-2019 HDL Subclass Proteomic Analysis and Functional Implication of Protein Dynamic Change During HDL Maturation Yuling Zhang Sun Yat-sen University, China Scott M. Gordon University of Kentucky, [email protected] Hang Xi Temple University Seungbum Choi Temple University Merlin Abner Paz Temple University See next page for additional authors RFoigllohtw c licthiks t aond ope addn ait feionedalba wckork fosr mat :inh att nps://uknoew tab to lewtle usdg kne.ukowy .hedu/cow thivrsc_fa documcpubent benefits oy u. Part of the Biology Commons, Cardiology Commons, and the Circulatory and Respiratory Physiology Commons Repository Citation Zhang, Yuling; Gordon, Scott M.; Xi, Hang; Choi, Seungbum; Paz, Merlin Abner; Sun, Runlu; Yang, William; Saredy, Jason; Khan, Mohsin; Remaley, Alan Thomas; Wang, Jing-Feng; Yang, Xiaofeng; and Wang, Hong, "HDL Subclass Proteomic Analysis and Functional Implication of Protein Dynamic Change During HDL Maturation" (2019). Saha Cardiovascular Research Center Faculty Publications. 42. https://uknowledge.uky.edu/cvrc_facpub/42 This Article is brought to you for free and open access by the Cardiovascular Research at UKnowledge. It has been accepted for inclusion in Saha Cardiovascular Research Center Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Authors Yuling Zhang, Scott M. Gordon, Hang Xi, Seungbum Choi, Merlin Abner Paz, Runlu Sun, William Yang, Jason Saredy, Mohsin Khan, Alan Thomas Remaley, Jing-Feng Wang, Xiaofeng Yang, and Hong Wang HDL Subclass Proteomic Analysis and Functional Implication of Protein Dynamic Change During HDL Maturation Notes/Citation Information Published in Redox Biology, v.
    [Show full text]
  • Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Is
    www.nature.com/scientificreports OPEN Low‑density lipoprotein receptor‑related protein 1 (LRP1) is a novel receptor for apolipoprotein A4 (APOA4) in adipose tissue Jie Qu1, Sarah Fourman1, Maureen Fitzgerald1, Min Liu1, Supna Nair2, Juan Oses‑Prieto2, Alma Burlingame2, John H. Morris2, W. Sean Davidson1, Patrick Tso1 & Aditi Bhargava3* Apolipoprotein A4 (APOA4) is one of the most abundant and versatile apolipoproteins facilitating lipid transport and metabolism. APOA4 is synthesized in the small intestine, packaged onto chylomicrons, secreted into intestinal lymph and transported via circulation to several tissues, including adipose. Since its discovery nearly 4 decades ago, to date, only platelet integrin αIIbβ3 has been identifed as APOA4 receptor in the plasma. Using co‑immunoprecipitation coupled with mass spectrometry, we probed the APOA4 interactome in mouse gonadal fat tissue, where ApoA4 gene is not transcribed but APOA4 protein is abundant. We demonstrate that lipoprotein receptor‑related protein 1 (LRP1) is the cognate receptor for APOA4 in adipose tissue. LRP1 colocalized with APOA4 in adipocytes; it interacted with APOA4 under fasting condition and their interaction was enhanced during lipid feeding concomitant with increased APOA4 levels in plasma. In 3T3‑L1 mature adipocytes, APOA4 promoted glucose uptake both in absence and presence of insulin in a dose‑dependent manner. Knockdown of LRP1 abrogated APOA4‑induced glucose uptake as well as activation of phosphatidylinositol 3 kinase (PI3K)‑mediated protein kinase B (AKT). Taken together, we identifed LRP1 as a novel receptor for APOA4 in promoting glucose uptake. Considering both APOA4 and LRP1 are multifunctional players in lipid and glucose metabolism, our fnding opens up a door to better understand the molecular mechanisms along APOA4‑LRP1 axis, whose dysregulation leads to obesity, cardiovascular disease, and diabetes.
    [Show full text]
  • Network Analysis of the Progranulin-Deficient Mouse Brain Proteome Reveals Pathogenic Mechanisms Shared in Human Frontotemporal
    Huang et al. acta neuropathol commun (2020) 8:163 https://doi.org/10.1186/s40478-020-01037-x RESEARCH Open Access Network analysis of the progranulin-defcient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations Meixiang Huang1,2,3, Erica Modeste2,4, Eric Dammer2,4, Paola Merino1,2, Georgia Taylor1,2, Duc M. Duong2,4, Qiudong Deng1,2,4, Christopher J. Holler1,2, Marla Gearing2,5,6, Dennis Dickson7, Nicholas T. Seyfried2,4,5 and Thomas Kukar1,2,5* Abstract Heterozygous, loss-of-function mutations in the granulin gene (GRN) encoding progranulin (PGRN) are a common cause of frontotemporal dementia (FTD). Homozygous GRN mutations cause neuronal ceroid lipofuscinosis-11 (CLN11), a lysosome storage disease. PGRN is a secreted glycoprotein that can be proteolytically cleaved into seven bioactive 6 kDa granulins. However, it is unclear how defciency of PGRN and granulins causes neurodegenera- tion. To gain insight into the mechanisms of FTD pathogenesis, we utilized Tandem Mass Tag isobaric labeling mass / spectrometry to perform an unbiased quantitative proteomic analysis of whole-brain tissue from wild type (Grn+ +) / and Grn knockout (Grn− −) mice at 3- and 19-months of age. At 3-months lysosomal proteins (i.e. Gns, Scarb2, Hexb) are selectively increased indicating lysosomal dysfunction is an early consequence of PGRN defciency. Additionally, proteins involved in lipid metabolism (Acly, Apoc3, Asah1, Gpld1, Ppt1, and Naaa) are decreased; suggesting lysoso- / mal degradation of lipids may be impaired in the Grn− − brain. Systems biology using weighted correlation network / analysis (WGCNA) of the Grn− − brain proteome identifed 26 modules of highly co-expressed proteins.
    [Show full text]
  • Data-Driven and Knowledge-Driven Computational Models of Angiogenesis in Application to Peripheral Arterial Disease
    DATA-DRIVEN AND KNOWLEDGE-DRIVEN COMPUTATIONAL MODELS OF ANGIOGENESIS IN APPLICATION TO PERIPHERAL ARTERIAL DISEASE by Liang-Hui Chu A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland March, 2015 © 2015 Liang-Hui Chu All Rights Reserved Abstract Angiogenesis, the formation of new blood vessels from pre-existing vessels, is involved in both physiological conditions (e.g. development, wound healing and exercise) and diseases (e.g. cancer, age-related macular degeneration, and ischemic diseases such as coronary artery disease and peripheral arterial disease). Peripheral arterial disease (PAD) affects approximately 8 to 12 million people in United States, especially those over the age of 50 and its prevalence is now comparable to that of coronary artery disease. To date, all clinical trials that includes stimulation of VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor) have failed. There is an unmet need to find novel genes and drug targets and predict potential therapeutics in PAD. We use the data-driven bioinformatic approach to identify angiogenesis-associated genes and predict new targets and repositioned drugs in PAD. We also formulate a mechanistic three- compartment model that includes the anti-angiogenic isoform VEGF165b. The thesis can serve as a framework for computational and experimental validations of novel drug targets and drugs in PAD. ii Acknowledgements I appreciate my advisor Dr. Aleksander S. Popel to guide my PhD studies for the five years at Johns Hopkins University. I also appreciate several professors on my thesis committee, Dr. Joel S. Bader, Dr.
    [Show full text]
  • Genome-Wide Association Study Identifies Loci Influencing Concentrations of Liver Enzymes in Plasma
    University of Texas Rio Grande Valley ScholarWorks @ UTRGV Health and Biomedical Sciences Faculty Publications and Presentations College of Health Professions 10-16-2011 Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma John C. Chambers Weihua Zhang Joban Sehmi Xinzhong Li Mark N. Wass See next page for additional authors Follow this and additional works at: https://scholarworks.utrgv.edu/hbs_fac Part of the Diseases Commons Recommended Citation Chambers, J., Zhang, W., Sehmi, J. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43, 1131–1138 (2011). https://doi.org/10.1038/ ng.970 This Article is brought to you for free and open access by the College of Health Professions at ScholarWorks @ UTRGV. It has been accepted for inclusion in Health and Biomedical Sciences Faculty Publications and Presentations by an authorized administrator of ScholarWorks @ UTRGV. For more information, please contact [email protected], [email protected]. Authors John C. Chambers, Weihua Zhang, Joban Sehmi, Xinzhong Li, Mark N. Wass, Pim Van der Harst, Hilma Holm, Serena Sanna, Maryam Kavousi, and Chun Xu This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/hbs_fac/93 NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2012 October 27. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Genet. ; 43(11): 1131–1138.
    [Show full text]
  • Molecular Characterization of Pluripotency in Embryos and Embryonic Stem Cells
    Molecular characterization of pluripotency in embryos and embryonic stem cells Memòria presentada per Josep Pareja Gómez per a optar al grau de doctor pel Departament de Ciències de la Salut i de la Vida de la Universitat Pompeu Fabra Tesis dirigida per el Dr. Nikica Zaninovic i la Dra. Anna Veiga Universitat Pompeu Fabra Dr. Nikica Zaninovic Dra. Anna Veiga Josep Pareja Gómez Director Directora Doctorand Between the fifth and the tenth day the lump stem cells differentiates into the overall building plan of the embryo and its organs. It is a bit like a lump of iron turning into the space shuttle. In fact it is the profoundest wonder we can still imagine and accept, and at the same time so usual that we have to force ourselves to wonder about the wondrousness of this wonder. Miroslav Holub. “Another brick in the wall” Tesi Villanueva ambiguously quoting Pink Floyd 1 Agraïments / Agradecimientos / Aknowledgements 2 Aquesta tesi ha costat déu i ajuda, però com que jo sóc ateu, intentaré enumerar l'ajuda: totes les persones que han fet possible que finalment aquest treball vegi la llum. Però són tantes, que per escriure aquests agraïments podria trigar gairebé tant com he trigat a escriure el que ve després. First, I would like to thank Dr. Zev Rosenwaks and my PhD advisor at the CRMI, Dr. Nikica Zaninovic for his generosity and support. My gratitude for allowing me to fulfill my scientific curiosity granting me the support to do it in, undoubtedly, the best embryology lab of the world. Thanks Nikica for encouraging me to always go scientifically a step further of what I had ever possibly imagined .
    [Show full text]